A study was

conducted to demonstrate the efficacy of afox

A study was

conducted to demonstrate the efficacy of afoxolaner against I. scapularis. The study was performed in the United States and was designed in accordance with standard methods for evaluating the efficacy of parasiticides for the treatment, check details prevention and control of tick infestations ( Marchiondo et al., 2013). It complied with Merial and local Institutional Animal Care and Use Committee requirements and international laws and ethics standards. Dogs were managed with regard to US Animal Welfare Regulations, 2008, 9 CFR ( USDA, 2008). The study involved 16 purpose bred beagles, which were individually identified by unique ear tattoos. Eight male and eight female dogs aged 6–8 months and weighing 5.2–8.7 kg were included. Dogs were in good health and had not been treated with ectoparasiticides for at least 3 months prior to the start of the study. Tick infestations and subsequent counts were performed prior to treatment and confirmed that the dogs were capable of maintaining adequate tick infestations. Dogs were housed individually. Health observations were conducted daily

throughout the study. In addition, health observations were conducted every hour for 4 h following treatment with afoxolaner on Day 0. The study followed a controlled, randomized block design, including 16 dogs (8 per group). Six days prior to treatment dogs were infested with 50 adult I. scapularis PLX4032 ticks, which were removed and counted 48 h later. The pre-treatment tick counts were used to allocate dogs to either the control or afoxolaner-treated group. Dogs in Group 1 were untreated controls. Dogs in Group 2 were treated once orally on Day 0 with the appropriate combination of soft chewables containing

afoxolaner. Chews weighing 0.5 g and containing 11.3 mg of afoxolaner were used. As the chewables are not designed to be divided, the dosing was administered as closely as possible to the minimum effective dose of 2.5 mg/kg using whole chews. The actual dosage administered to the dogs ranged from 2.7 to 3.7 mg/kg of body crotamiton weight. Dogs were infested with 50 adult ticks on the day prior to treatment (Day −1) and on Days 7, 14, 21, and 28. Forty-eight hours after treatment and 48 h after each of the subsequent re-infestations, ticks were removed and live ticks counted. These counts were conducted during a process that involved methodical examination of all body areas using finger tips and/or a coarse tooth comb to sort through the hair and locate all ticks on the animal, as described by Marchiondo et al. (2013). The I. scapularis ticks used in this study were unfed adult ticks, approximately 50% male and 50% female, collected from the wild in the USA. Personnel responsible for collection of animal health and efficacy data were blinded to the treatment groups. Total counts of live ticks were transformed to the natural logarithm of (count + 1) for calculation of geometric means by treatment group at each time point.

Related posts:

  1. No examination was conducted prior to enrolment to the study
  2. 5-HT Receptor mutations all appear to constitutive activation of the kinase
  3. All efficacy and safety outcomes had been assessed by an independent, central ad
  4. Efficacy against mild influenza for A/H3N2 and B strains was 94 3
  5. In cases like this when there is a tie in efficacy, the highest d
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>